Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.
about
Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma.Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignanciesDevelopment of a liver-specific Tet-on inducible system for AAV vectors and its application in the treatment of liver cancerThe promise of gene therapy in gastrointestinal and liver diseases.Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact.Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice.Development of a High-Throughput Molecular Imaging-Based Orthotopic Hepatocellular Carcinoma ModelGene therapy of liver diseases.Gene- and immunotherapy for hepatocellular carcinoma.Immunotherapeutic synergy between anti-CD137 mAb and intratumoral administration of a cytopathic Semliki Forest virus encoding IL-12.Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccinesTherapy of cancer by cytokines mediated by gene therapy approach.Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs).Virotherapy, gene transfer and immunostimulatory monoclonal antibodies.Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression.Gene therapy: regulations, ethics and its practicalities in liver disease.Immunotherapy for liver tumors: present status and future prospects.Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis.Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma.The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.Cellular and molecular mechanisms of hepatocellular carcinoma: an update.Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis.Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma.Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally.Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo.Neural stem cell-based gene therapy for brain tumors.Circulating pro- and anti-angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma.Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin-12.Combined gene therapy of endostatin and interleukin 12 with polyvinylpyrrolidone induces a potent antitumor effect on hepatoma.Construction of a targeting adenoviral vector carrying AFP promoter for expressing EGFP gene in AFP-producing hepatocarcinoma cell.Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12.Construction of IL-2 gene-modified human hepatocyte and its cultivation with microcarrier.Gene therapy of liver cancer.Models of hepatocellular carcinoma and biomarker strategy.Adjuvant interleukin-12 gene therapy for the management of colorectal liver metastases.Interleukin-12 gene therapy for hepatocellular carcinoma: a dream come true?Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12.
P2860
Q24815069-0DFA52D1-1F31-4571-BACD-0575929EAC51Q30724968-85FC42C2-C9F3-4AF7-9708-194CCE661C44Q34482357-F9370B4A-7067-4C5E-8450-89BA7CE1D056Q35086111-95B023DE-CC07-40CF-97C6-B8364772453DQ35090229-5D1FC1DA-C20B-4577-830B-5E40046EB089Q35208038-6FFB9228-88F8-4724-B874-6BF8FA433866Q35766493-22A1CD0E-7ACD-42F1-8C4D-811804ABCB97Q35827586-A4D2CF2F-A1F7-4926-A6AE-65390E3BC2AFQ35842662-690352EE-CD0D-447D-9D39-BF84631130F7Q36150432-63FF4277-8571-4853-A1F3-8E10FF03B591Q36220613-A12F55AD-B161-4AC9-9587-A8F62BB6DCA7Q36308644-9C689A3D-D231-436C-8CA5-BF11060BA252Q36394987-647BEF90-553F-4538-88E8-1D31035B79D4Q36418759-D405A48C-64D5-4900-94E5-54EF0E38236DQ36456487-E06B6BF5-AE1E-4E6C-9388-1048A74E2B14Q36930091-96990510-6880-42E5-B05A-D63A72FD0D52Q37139713-4D9B385B-7F95-4881-8E00-4142E05B07D9Q37144014-E35D0305-AB9C-48DB-86DB-E1B98759840CQ37346066-5DFF266C-BA8B-46A4-A8D4-1FF7CDDB80FEQ37452091-B14EAD06-EA31-4305-934E-E062DBDA24D3Q37800217-DD86385F-94C7-432A-B56B-8440B4E52612Q38046107-10C646C4-0A6F-463A-BD6F-D90BEE496642Q38522757-8C3D2139-8B84-4C71-B9E9-C8131C32AAB0Q38527482-753C36AE-704A-41B7-8058-6CB05DD8410BQ38635000-F04350B3-BFEB-4A90-994B-0A5DE793D33BQ38703318-6D69778A-64E6-47AB-9954-DDB40994AEEEQ39043844-E4C1CC21-ADA0-492B-A3C8-5D4AB9BE8855Q39101230-F299E470-1E1D-45C8-958A-7EFCFAB83686Q39137284-805ABC0E-24AA-449E-825F-9E1E56C31C39Q39506866-BF731B23-8619-4C14-B8EA-A69940971A1EQ40525817-AAC33775-3680-4520-B2D6-ED2F067D2E29Q40534219-6EE155CA-082E-41A9-9EB6-ED5741385032Q40600361-0ABFC167-714D-4720-BA50-59BEBD0A990FQ41132577-BB7C1AFF-F550-4809-8E92-DF9BDCBBA122Q42695574-24FBE302-A196-498F-AF00-62FE0F1B2524Q42726362-EB4406E2-B3B2-4911-9339-0C145085C3DBQ42872868-4E25DB04-A5C9-4083-A77B-7DF7C85DD3BDQ45096926-EAD29D20-51BA-450A-9BCD-9F54B604C31FQ45878031-EB57EE5F-ADCB-4639-87E1-CCFBE115575CQ45883442-91AD2E57-E4DA-4CEE-AC9C-6EF17F77AEEB
P2860
Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Gene therapy of orthotopic hep ...... rus coding for interleukin 12.
@en
type
label
Gene therapy of orthotopic hep ...... rus coding for interleukin 12.
@en
prefLabel
Gene therapy of orthotopic hep ...... rus coding for interleukin 12.
@en
P2093
P50
P921
P356
P1433
P1476
Gene therapy of orthotopic hep ...... irus coding for interleukin 12
@en
P2093
P356
10.1053/JHEP.2001.20796
P407
P577
2001-01-01T00:00:00Z